These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11784128)

  • 1. Looking for selectivity among cytochrome P450s inhibitors.
    Cavalli A; Recanatini M
    J Med Chem; 2002 Jan; 45(2):251-4. PubMed ID: 11784128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
    Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW
    J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of the P450 enzymes aromatase and lyase. Crystallographic and molecular modeling studies suggest structural features of pyridylacetic acid derivatives responsible for differences in enzyme inhibitory activity.
    Laughton CA; Neidle S
    J Med Chem; 1990 Nov; 33(11):3055-60. PubMed ID: 2231605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology modelling of the enzyme P450 17 alpha-hydroxylase/17,20-lyase--a target for prostate cancer chemotherapy--from the crystal structure of P450BM-3.
    Burke DF; Laughton CA; Neidle S
    Anticancer Drug Des; 1997 Mar; 12(2):113-23. PubMed ID: 9113066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure.
    Lewis DF; Lee-Robichaud P
    J Steroid Biochem Mol Biol; 1998 Aug; 66(4):217-33. PubMed ID: 9744519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active site-directed inhibitors of steroid hydroxylase cytochromes P450.
    Vickery LE
    Methods Enzymol; 1991; 206():548-58. PubMed ID: 1784241
    [No Abstract]   [Full Text] [Related]  

  • 7. Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.
    Iwasaki M; Lindberg RL; Juvonen RO; Negishi M
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):569-73. PubMed ID: 8484736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach.
    Cavalli A; Bisi A; Bertucci C; Rosini C; Paluszcak A; Gobbi S; Giorgio E; Rampa A; Belluti F; Piazzi L; Valenti P; Hartmann RW; Recanatini M
    J Med Chem; 2005 Nov; 48(23):7282-9. PubMed ID: 16279787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular model for the enzyme cytochrome P450(17 alpha), a major target for the chemotherapy of prostatic cancer.
    Laughton CA; Neidle S; Zvelebil MJ; Sternberg MJ
    Biochem Biophys Res Commun; 1990 Sep; 171(3):1160-7. PubMed ID: 2222435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.
    Auchus RJ; Miller WL
    Mol Endocrinol; 1999 Jul; 13(7):1169-82. PubMed ID: 10406467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive CYP2C9 inhibitors: enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis.
    Afzelius L; Zamora I; Ridderström M; Andersson TB; Karlén A; Masimirembwa CM
    Mol Pharmacol; 2001 Apr; 59(4):909-19. PubMed ID: 11259637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17.
    Wächter GA; Hartmann RW; Sergejew T; Grün GL; Ledergerber D
    J Med Chem; 1996 Feb; 39(4):834-41. PubMed ID: 8632407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy.
    Haider SM; Patel JS; Poojari CS; Neidle S
    J Mol Biol; 2010 Jul; 400(5):1078-98. PubMed ID: 20595043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis.
    Gobbi S; Hu Q; Zimmer C; Engel M; Belluti F; Rampa A; Hartmann RW; Bisi A
    J Med Chem; 2016 Mar; 59(6):2468-77. PubMed ID: 26938274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the CYP3A4 active site by homology modeling.
    Tanaka T; Okuda T; Yamamoto Y
    Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):830-5. PubMed ID: 15256703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase.
    Chen S; Kao YC; Laughton CA
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):107-15. PubMed ID: 9365179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4.
    Szklarz GD; He YQ; Kedzie KM; Halpert JR; Burnett VL
    Arch Biochem Biophys; 1996 Mar; 327(2):308-18. PubMed ID: 8619620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.
    Ji H; Zhang W; Zhou Y; Zhang M; Zhu J; Song Y; Lü J
    J Med Chem; 2000 Jun; 43(13):2493-505. PubMed ID: 10891108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional model of cytochrome P450 human aromatase.
    Loge C; Le Borgne M; Marchand P; Robert JM; Le Baut G; Palzer M; Hartmann RW
    J Enzyme Inhib Med Chem; 2005 Dec; 20(6):581-5. PubMed ID: 16408794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
    Narasimhulu S
    Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.